Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Nominee Khan Is Likely To Face Close Senate Vote; Biden Still Has One More Seat To Fill

Executive Summary

Columbia’s Khan is known for her critical views of tech industry, which observers expect will transfer to pharma; another possible nominee for the other remaining spot, DC attorney general Karl Racine, is also focused on the tech space. Acting Chair Rebecca Kelly Slaughter’s pharma interest likely means the issue won’t recede from the FTC’s agenda.

You may also be interested in...



Pharma Mergers May Have Tougher Time Clearing FTC Under New Review Scheme

FTC is working with Canadian and European enforcement agencies to come up with new approach to merger reviews that could look at effects on innovation and companies' past conduct. FTC to review closed mergers to see if corrective action is necessary, FTC acting chair says.

FTC Shift Under Biden Administration Begins With Chairman Simons, Senior Staff Resigning

While expected following start of Biden administration, Simon’s resignation is “somewhat of a surprise” considering it will change the balance of power to the Democrats ahead of when his term would have been ended, says advertising law attorney Ivan Wasserman.

Products Distributed In Bulk Could Pump Up Already Large OTC Sanitizer Problem In US

“Regardless of whether the adulterated products are sold on store shelves, online to consumers, or in bulk format to businesses and other organizations, FDA’s priority is safety," says American Cleaning Institute VP James Kim.

Topics

UsernamePublicRestriction

Register

PS144050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel